High C content molecules for C implant

Information

  • Patent Grant
  • 8343860
  • Patent Number
    8,343,860
  • Date Filed
    Friday, March 4, 2011
    13 years ago
  • Date Issued
    Tuesday, January 1, 2013
    11 years ago
Abstract
The present invention provides molecules with high carbon content for Carbon-containing species implant in semiconductor material. The molecules can be used in various doping techniques such as ion implant, plasma doping or derivates methods.
Description
TECHNICAL FIELD

Disclosed herein are non-limiting embodiments of compositions and methods used in the manufacture of semiconductor, photovoltaic, LCD-TFT, or flat panel type devices.


BACKGROUND ART

Carbon is a commonly used implant species. It can be implanted alone for carbon doping. Alternatively carbon and one or more other species are used to form a heterogeneous doping. In this case the carbon ion is called a co-implant for the other species, generally a pre-amorphization implant (PAI) species such as Germanium, Phosphorous or Boron. The carbon is positioned between a shallow dopant and end-of-range (EOR) damage caused by the PAI species. The carbon acting as a substituent here will block some interstitials coming back from EOR during the annealing step. It would then avoid transient enhanced diffusion (TED) or boron interstitial cluster formation (BIC). Carbon range also often overlaps with the PAI species and contributes to PAI by itself. Another application of carbon doping is to create compressive strain. In a source/drain in a transistor device created from SIC, carbon implantation will cause tensile strain in the channel. This stress is beneficial for NMOS for instance.


Carbon implantation is challenging. It can be done by epitaxial growth or high dose implant however this can cause amorphization of the silicon re-grown.


Many molecules and techniques have been used for carbon implant. For instance, Hatem, et al. (US 20090200494 A1, Varian) describes the use of a cold implantation process. They describe a low temperature process using gases such as methane, ethane, propane, bibenzyl, butane and pyrene (C16H10) or possible using molecular carbon in combination with diborane, pentaborane, carborane, octaborane, decaborane, or octadecaborane.


Jagannathan et al. (US2002160587A1, IBM) described the doping of Si or SiGe using boron or carbon for heterojunction bipolar transistors (HTB). The carbon containing gas is C2H4.


Jacobson et al. (US2008299749A1) described a method for cluster ion implantation for defect engineering. The method consists of implanting using an ion beam formed from ionized molecules. In the method, molecular cluster dopant ions are implanted into a substrate with or without a co-implant of non-dopant cluster ion (carbon cluster ion for instance). The dopant ion is implanted into the amorphous layer created by the co-implant in order to reduce defects in the crystalline structure (and reducing the leakage current thus improving the performances of the semiconductor junctions). The use of CnH+ type molecules is generally described and more specifically the use of C16H10 solid and not volatile with a high temperature melting point) and C7H7.


Suitable techniques that can be used for carbon implantation include standard ion beam (beamline), plasma doping, or pulsed plasma doping (P2LAD), plasma Immersion Ion Implantation (PI3), including the many related variants of these techniques known in the art.







DISCLOSURE OF THE INVENTION

The present invention is related to a method of manufacturing semiconductor devices in which the carbon doping is done using high carbon content molecules.


In one embodiment, molecules with high carbon content and low hydrogen to carbon ratio (C:H>0.6, preferably >1) are used as the carbon source molecule for carbon ion implantation.


In another embodiment, implanting carbon with a co-implant of Boron or other atoms can enhance devices properties as discussed in the background. The boron co-implant can be accomplished using standard boron compounds such as B18H22, BF3, diborane, decaborane or a boron cluster. In other aspects, the method may include implanting the target material with other species such as Germanium, Phosphorous, Silicon, Arsenic, Xenon, Nitrogen, Aluminum, Magnesium, Silver, Gold, Fluorine, and combinations thereof.


In some embodiments, the method may be used to create material strain and fabricate an ultra-shallow junction in the target material.


The Invention may be further defined in part by the following numbered sentences:

  • 1. A method of implanting carbon into a substrate, the method comprising, consisting essentially of, or consisting of a step of carbon implantation into the substrate with a starting carbon source molecule having a carbon to hydrogen ratio equal to or more than 0.6, preferably more than 1.
  • 2. The method of sentence 1, wherein the carbon implantation step is performed by an ion beam (beamline), plasma doping or pulsed plasma doping (P2LAD), or Plasma Immersion Ion Implantation (PI3) process.
  • 3. The method of sentences 1 or 2, wherein the carbon is co-implanted with other element(s).
  • 4. The method of sentences 1, 2, or 3, wherein the other element(s) is implanted by the same and/or a separate step of implantation by an ion beam (beamline), plasma doping or pulsed plasma doping (P2LAD), or Plasma Immersion Ion Implantation (PI3) process.
  • 5. The method of sentences 3 or 4 wherein at least one of the other element(s) co-implanted is selected within Germanium, Phosphorous, Silicon, Arsenic, Xenon, Nitrogen, Aluminum, Magnesium, Silver, Gold, Boron or Fluorine.
  • 6. The method of sentence 5, wherein the element(s) co-implanted include Boron provided as a boron cluster, B18H22, BF3, diborane or decaborane.
  • 7. The method of sentences 1, 2, 3, 4, 5, or 6 wherein the implantation is followed by an annealing step such as a thermal and/or UV annealing.
  • 8. The method of sentences 1, 2, 3, 4, 5, 6, or 7, wherein the carbon source molecule comprises C6F6.
  • 9. The method of method of sentences 1, 2, 3, 4, 5, 6, 7 or 8, wherein the carbon source molecule comprises one or more of diphenylacetylene, naphthalene, azulene, cyclooctatetraene, benzene, norbornadiene, cycloheptatriene, cyclohexadiene, cyclopentadiene, pentadiene, hexadiene, diethynylbenzene, phenylacetylene, phenylpropyne, ethynyltoluene, hexadiyne, phenyl butyne, 2,5-heptadiyne, (tButyl)phenylacetylene, methylbutenyne, cyclopropylacetylene, ethynylcyclohexene, cyclopentylacetylene, cyclohexylacetylene and dimethylbutyne.
  • 10. The method of method of sentences 1, 2, 3, 4, 5, 6, 7 or 8, wherein the carbon source molecule comprises acetylene.
  • 11. The method of sentences 1, 2, 3, 4, 5, 6, or 7, wherein the carbon source molecule is represented by the general formula CxHy with x and y being an integer >0.
  • 12. The method of sentence 11, wherein x/y ratio is >0.6.
  • 13. The method of sentence 12, wherein the ratio x/y≦1.
  • 14. The method of sentences 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13, wherein the implantation step comprises a reaction in a plasma that leads to the generation of a new molecular species, preferably a molecule or molecular cluster having 5 or more carbon atoms, that is the molecular species implanted into the substrate.
  • 15. The method of sentences 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14, wherein the new molecular species contains at least one ring strain and/or one or more unsaturated bonds.


MODES FOR CARRYING OUT THE INVENTION

Carbon implantation may be performed by any know procedure in the art including:


Ion beam (beamline) implantation may be used as described in I. P. Jain and Garima Agarwal, Ion beam induced surface and interface engineering, Surface Science Reports, Volume 66, Issues 3-4, March 2011, Pages 77-172, ISSN 0167-5729, DOI: 10.1016/j.surfrep.2010.11.001.


Plasma doping or pulsed plasma doping (P2LAD) may be used as described in Felch, S. B, Fang, Z., Kao, B.-W., Liebert, R. B., Walther, S. R., Hacker, D. Plasma doping for the fabrication of ultra-shallow junctions (2002) Surface and Coatings Technology, 156 (1-3), pp. 229-236.


Any hydrogen co-implanted may, as needed, be removed thereafter by an annealing step such as a standard thermal annealing and/or a UV photoannealing step.


Preferred carbon source molecules for carbon implantation are listed in














TABLE 1







Melting
Boiling
Vapor





point
Point
Pressure
[C/H]


Name
Formula
(C.)
(C.)
(Torr)
ratio




















C6F6
C6F6
4
81
95







(25 C.)



Diphenylacetylene
C14H10
62.5
300
20
1.4






(170 C.) 



Naphtalene
C10H8
80
218
1
1.25






(53 C.)



Azulene
C10H8
100
242
0.0091
1.25






(25 C.)



Cyclooctatetraene
C8H8
−5
142
7.9
1






(25 C.)



Benzene
C6H6
5.5
80
100
1






(26 C.)



Acetylene
H—C≡C—H
NA
−84
33400
1






(20 C.)



BCHD
C7H8
−19
89
50
0.88






(20 C.)



Cycloheptatriene
C7H8
−80
116
18
0.88






(20 C.)



Cyclopentadiene
C5H6
−85
41
400
0.83






(20 C.)



Cyclohexadiene
C6H8
−49
88
77
0.75






(25 C.)



Pentadiene
C5H8
−87
42
620
0.63






(37 C.)



Hexadiene
C6H10
−141
60
367
0.6






(37 C.)



Diethynylbenzene
C10H6
Solid
188 C.
14
1.67



1785-61-1


(78 C.)



Phenylacetylene
C8H6
−45 C.
142 C.
7
1.3



536-74-3


(25 C.)



Phenyl propyne
C9H8
Liquid
183
1.2
1.125



673-32-5
<20 C.

(25 C.)



Phenyl propyne
C9H8
Liquid
NA
20
1.125



10147-11-2
<20 C.

(75 C.)



Ethynyltoluene
C9H8
Liquid
168 C.
NA
1.125



766-97-2
<20 C.





Hexadiyne
C6H6
68
128 C.
~12
1



2809-69-0


(25 C.)



Phenyl butyne
C10H10
Liquid
190 C.
NA
1



16520-62-0
<20 C.





2,5-Heptadiyne
C7H8
NA
1400
7
0.88



50428-63-2

(est.)
(25 C.)







(est.)



(tButyl)
C12H14
Liquid
NA
2
0.857


phenylacetylene
772-38-3


(70 C.)



Methylbutenyne
C5H6
−113
32
750
0.83



78-80-8


(30 C.)



Cyclopropyl
C5H6
Liquid
52-65 C.
NA
0.83


acetylene
6746-94-7






Ethynylcyclo-
C8H10
Liquid
~150
~5
0.8


hexene
931-49-7
<20 C.

(25 C.)



cyclopentyl-
C7H10
Liquid
105
NA
0.7


acetylene
930-51-8
<20 C.





Cyclohexyl-
C8H12
Liquid
130
NA
0.67


acetylene
931-48-6
<20 C.





dimethylbutyne
C6H10
−78
37
410
0.6



917-92-0


(20 C.)










C6F6 is a preferred combination carbon and fluorine source molecule for co-implantation of both carbon and fluorine. C6F6 ionization yields C5F3+ as an active implant species.


Ionic species derived from a carbon source molecule are generally the more active implantation species. The carbon source molecules of Table 1 are preferred in part because of their ionization patterns, some of which are demonstrated in the following ionization data:


1,3-Cyclohexadiene ionization yields C6H7+.


1,3-hexadiene ionization yields C5H7+; C6H9+; C4H6+.


Acetylene ionization yields predominant species C2H2+; C2H+.


Cycloheptatriene ionization yields C2H3+; C3H3+; C4H3+; C5H3+; C5H5+; C7H7+; C7H8+.


1,6-heptadiyne ionization yields C2H3+; C3H3+; C4H3+; C5H3+; C5H5+; C7H7+; C7H8+.


Norbornadiene ionization yields C2H3+; C3H3+; C4H3+; C5H3+; C5H5+; C7H7+; C7H8+.


Naphtalene ionization yields C10H7+.


1,2,5,7-cyclooctatetraene ionization yields C8H7+; C6H6; C4H4; C3H3; C2H3.


Benzene ionization yields C6H5+.


1,3-cyclopentadiene ionization yields C5H5+; C3H4; C3H3+.


1,4-pentadiene ionization yields C5H7+; C4H5+; C3H3+.


1,5-hexadiene ionization yields C5H7+; C3H6+; C4H6+; C3H3+.


1,4-diethynylbenzene ionization yields C10H6)


Phenylacetylene ionization yields C8H5+.


2,4-hexadiyne ionization yields C4H3+; C4H4+.


Methylbutenyne ionization yields C5H5+; C3H4+; C3H3+; C4H3+; C4H2+.


Ethynylcyclopropane ionization yields C5H5+.


It will be understood that many additional changes in the details, materials, steps, and arrangement of parts, which have been herein described and illustrated in order to explain the nature of the invention, may be made by those skilled in the art within the principle and scope of the invention as expressed in the appended claims. Thus, the present invention is not intended to be limited to the specific embodiments in the examples given above and/or the attached drawings.

Claims
  • 1. A method of implanting carbon into a substrate, comprising a step of carbon implantation into the substrate with a starting carbon source molecule selected from one or more of cyclooctatetraene, norbornadiene, cycloheptatriene, cyclohexadiene, cyclopentadiene, pentadiene, hexadiene, hexadiene, 1,5-hetadiyne, methylbutenyne, cyclopropylacetylene, ethynylcyclohexene, cyclopentylacetylene, cyclohexylacetylene, C6F6 and methylbutyne.
  • 2. The method of claim 1, wherein the carbon implantation step is performed by an ion beam (beamline), plasma doping or pulsed plasma doping (P2LAD), or Plasma Immersion Ion Implantation (PI3) process.
  • 3. The method of claim 2, wherein the carbon is co-implanted with other element(s).
  • 4. The method of claim 3, wherein the other element(s) is implanted by the same and/or a separate step of implantation by an ion beam (beamline), plasma doping or pulsed plasma doping (P2LAD), or Plasma Immersion Ion Implantation (PI3) process.
  • 5. The method of claim 4, wherein at least one of the other element(s) co-implanted is selected within Germanium, Phosphorous, Silicon, Arsenic, Xenon, Nitrogen, Aluminum, Magnesium, Silver, Gold, Boron or Fluorine.
  • 6. The method of claim 5, wherein the element(s) co-implanted include Boron provided as a boron cluster, B18H22, BF3, diborane or decaborane.
  • 7. The method of claim 1, wherein the implantation is followed by an annealing step.
  • 8. The method of method of claim 1, wherein the carbon source molecule further comprises acetylene.
  • 9. The method of claim 1, wherein the new molecular species contains at least one ring strain and/or one or more unsaturated bonds.
US Referenced Citations (12)
Number Name Date Kind
5089746 Rosenblum et al. Feb 1992 A
7393765 Hanawa et al. Jul 2008 B2
20020160587 Jagannathan et al. Oct 2002 A1
20060019039 Hanawa et al. Jan 2006 A1
20070238234 Wang et al. Oct 2007 A1
20080299749 Jacobson et al. Dec 2008 A1
20090200494 Hatem et al. Aug 2009 A1
20090286367 Krull et al. Nov 2009 A1
20100029053 Itokawa et al. Feb 2010 A1
20100112795 Kaim et al. May 2010 A1
20110002011 Endo Jan 2011 A1
20110171817 Lee et al. Jul 2011 A1
Foreign Referenced Citations (1)
Number Date Country
WO 2007 070321 Jun 2007 WO
Provisional Applications (1)
Number Date Country
61316678 Mar 2010 US